Topical Azithromycin Ophthalmic Solution (AzaSite)

Type: drug

Status: FDA Approved

Developer: Inspire Pharmaceuticals (now Merck)

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026